The US Food and Drug Administration (FDA) frequently stress the
importance of enrolling diverse patient populations in clinical trials
conducted to support product applications. Meg Egan Auderset
at Clarivate Analytics discusses the multiple recommendations
from FDA and how sponsors can meet agency expectations to get
products approved.
